These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 8739213)

  • 1. N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation.
    Mazzari S; Canella R; Petrelli L; Marcolongo G; Leon A
    Eur J Pharmacol; 1996 Apr; 300(3):227-36. PubMed ID: 8739213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide.
    Facci L; Dal Toso R; Romanello S; Buriani A; Skaper SD; Leon A
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3376-80. PubMed ID: 7724569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat.
    Conti S; Costa B; Colleoni M; Parolaro D; Giagnoni G
    Br J Pharmacol; 2002 Jan; 135(1):181-7. PubMed ID: 11786493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cannabinoid CB2 receptor selective agonist JWH133 reduces mast cell oedema in response to compound 48/80 in vivo but not the release of beta-hexosaminidase from skin slices in vitro.
    Jonsson KO; Persson E; Fowler CJ
    Life Sci; 2006 Jan; 78(6):598-606. PubMed ID: 16111718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proposed autacoid mechanism controlling mastocyte behaviour.
    Aloe L; Leon A; Levi-Montalcini R
    Agents Actions; 1993; 39 Spec No():C145-7. PubMed ID: 7505999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity.
    Petrosino S; Schiano Moriello A; Verde R; Allarà M; Imperatore R; Ligresti A; Mahmoud AM; Peritore AF; Iannotti FA; Di Marzo V
    J Neuroinflammation; 2019 Dec; 16(1):274. PubMed ID: 31878942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons.
    Skaper SD; Buriani A; Dal Toso R; Petrelli L; Romanello S; Facci L; Leon A
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3984-9. PubMed ID: 8633002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amitriptyline, clomipramine, and maprotiline attenuate the inflammatory response by inhibiting neutrophil migration and mast cell degranulation.
    Gurgel JA; Lima-Júnior RC; Rabelo CO; Pessoa BB; Brito GA; Ribeiro RA
    Braz J Psychiatry; 2013; 35(4):387-92. PubMed ID: 24402214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A saturated N-acylethanolamine other than N-palmitoyl ethanolamine with anti-inflammatory properties: a neglected story..
    Dalle Carbonare M; Del Giudice E; Stecca A; Colavito D; Fabris M; D'Arrigo A; Bernardini D; Dam M; Leon A
    J Neuroendocrinol; 2008 May; 20 Suppl 1():26-34. PubMed ID: 18426496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights in mast cell modulation by palmitoylethanolamide.
    De Filippis D; Negro L; Vaia M; Cinelli MP; Iuvone T
    CNS Neurol Disord Drug Targets; 2013 Feb; 12(1):78-83. PubMed ID: 23394523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodixanol activation of mast cells: Implications in the pathogenesis of iodixanol-induced delayed cutaneous adverse reactions.
    Zou W; Yang S; Chen L; Hu S; Hao G; Hu C
    Toxicology; 2022 Jan; 465():153034. PubMed ID: 34774977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the anti-inflammatory and anti-nociceptive activity of nitroaspirin and aspirin.
    al-Swayeh OA; Clifford RH; del Soldato P; Moore PK
    Br J Pharmacol; 2000 Jan; 129(2):343-50. PubMed ID: 10694241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of plasma extravasation by abruquinone A, a natural isoflavanquinone isolated from Abrus precatorius.
    Wang JP; Hsu MF; Chang LC; Kuo JS; Kuo SC
    Eur J Pharmacol; 1995 Jan; 273(1-2):73-81. PubMed ID: 7537681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of inflammatory paw oedema by cysteamine in the rat.
    Salam OM
    Pharmacol Res; 2002 Apr; 45(4):275-84. PubMed ID: 12030790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNFalpha release from canine skin mast cells.
    Cerrato S; Brazis P; della Valle MF; Miolo A; Puigdemont A
    Vet Immunol Immunopathol; 2010 Jan; 133(1):9-15. PubMed ID: 19625089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterisation of the somatostatin analogue TT-232: effects on neurogenic and non-neurogenic inflammation and neuropathic hyperalgesia.
    Pintér E; Helyes Z; Németh J; Pórszász R; Pethö G; Thán M; Kéri G; Horváth A; Jakab B; Szolcsányi J
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):142-50. PubMed ID: 12122501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral administration of Ginkgo biloba extract, EGb-761 inhibits thermal hyperalgesia in rodent models of inflammatory and post-surgical pain.
    Biddlestone L; Corbett AD; Dolan S
    Br J Pharmacol; 2007 May; 151(2):285-91. PubMed ID: 17375081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models.
    Britti D; Crupi R; Impellizzeri D; Gugliandolo E; Fusco R; Schievano C; Morittu VM; Evangelista M; Di Paola R; Cuzzocrea S
    BMC Vet Res; 2017 Aug; 13(1):229. PubMed ID: 28768536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor bearing decreases systemic acute inflammation in rats--role of mast cell degranulation.
    Barbosa AL; Pinheiro CA; Oliveira GJ; Moraes MO; Ribeiro RA; Vale ML; Souza MH
    Inflamm Res; 2009 May; 58(5):235-40. PubMed ID: 19199089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats.
    De Filippis D; Luongo L; Cipriano M; Palazzo E; Cinelli MP; de Novellis V; Maione S; Iuvone T
    Mol Pain; 2011 Jan; 7():3. PubMed ID: 21219627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.